StockNews.com Begins Coverage on Athersys (NASDAQ:ATHX)
Equities researchers at StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research report issued on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Athersys Price Performance Athersys has a twelve month low of $0.01 and a twelve month high of $1.99. The firm has a […]
Equities researchers at StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research report issued on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Athersys Price Performance Athersys has a twelve month low of $0.01 and a twelve month high of $1.99. The firm has a […]
